NCT01091480

French Hypertrophic Cardiomyopathy Observatory

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 600 (estimated)
• Sponsor: French Cardiology Society · Academic / Other
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use. The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of origin or not) in France (diagnosis, treatment)

Detailed description

This both retrospective and prospective study is proposed to cardiology services 50 hospitals in France. A cardiologist referral is designated for each facility. The following data will be collected by the physician during the initial hospitalization * Demographics * Geographic origin of patient * Clinical data: criteria for inclusion and non-inclusion data HCM general, Doppler ultrasound, personal history, family history * Reviews made: non-organic, biological * Family Survey, * Treatments: Medical, Electrical, invasive * Data from hospital The follow-up to 18 months, 3 years and 5 years will be conducted by clinical-research-technicians of the French Society of Cardiology, an application will be made to municipalities of birth and mail a letter to physicians and patients. The following data will be collected: * Vital status * Data from hospital * Reviews made: non-organic, biological * Treatments: Medical, Electrical, invasive

Conditions

• Hypertrophic Cardiomyopathy

Timeline

• Start date: 2010-01-01
• Primary completion: 2023-12-01
• Completion: 2028-12-01
• First posted: 2010-03-24
• Last updated: 2022-09-21

Locations

1 site across 1 country: France